医学
腺癌
全肺切除术
标准摄取值
肺
病态的
肺癌
放射科
正电子发射断层摄影术
核医学
内科学
癌症
作者
Okan Falay,Fatih Selçukbırıcık,Serhan Tanju,Suat Erus,Murat Kapdağlı,Ekin Ezgi Cesur,Ömer Yavuz,Pınar Bulutay,Pınar Fırat,Nil Molinas Mandel,Şükrü Dilege
出处
期刊:Nuclear Medicine Communications
[Ovid Technologies (Wolters Kluwer)]
日期:2021-03-30
卷期号:42 (8): 922-927
被引量:5
标识
DOI:10.1097/mnm.0000000000001414
摘要
In lung adenocarcinoma cases, 'spread through air spaces' (STAS) is a new indicator of invasion and directly related to disease survival. The aim of our study is to establish whether a preoperatively performed 18F-Fluorodeoxyglucose (FDG) PET/computed tomography (CT) imaging data can predict the presence of STAS in cases with lung adenocarcinoma and thus predict the decision for the type of surgery and adjuvant chemotherapy.Between 2000 and 2019, we retrospectively analyzed 63 patients with lung adenocarcinoma cases that had undergone lobectomy or pneumonectomy. Semiquantitative parameters were calculated and metabolic tumor volume (MTV)/CT volume (CTV) ratio was recorded from FDG PET/CT data. The pathological samples from these patients were evaluated for STAS. All these values were evaluated for their correlation with the alveolar spread.There was no statistically significant correlation to be found between CTV, MTV, total lesion glycolysis (TLG), standardized uptake value (SUV)max, SUVmean and STAS (P > 0.05). However, MTV/CTV ratio above 1 had statistically more alveolar spread. In the group with an MTV ratio above 1, STAS positivity was 27 (75%), and 9 (25%) did not have STAS, whereas these were 6 (22.2%) patients who had STAS, and 21 (77.8%) did not have STAS in the group with below 1 (P < 0.001).In the preoperative PET study inoperable lung adenocarcinoma cases, MTV/CTV ratio higher than 1 was found to predict STAS positivity. As a result, it was found that it provided significant clinical additional information regarding the need for a surgical approach (lobar resection instead of sublobar) and adjuvant chemotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI